New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more

Although psychedelic drugs have shown promise in the treatment of multiple diseases, research into these compounds has been stymied. Johns Hopkins is trying to remedy that with a new, privately funded center for psychedelic research.